SKI Market

A+| A| A-|

Indian Indices

Sensex

76,361.53 -502.18
( -0.65%)

Global Indices

Nasdaq

47,431.94 -295.58
(-0.62%)

Dow Jones

6,795.43 -7.05
(-0.10%)

Hang Seng

55,018.23 769.84
(1.42%)

Nikkei 225

10,315.38 -96.86
(-0.93%)

Forex

USD-INR

91.90 -0.24
(-0.26%)

EUR-INR

106.87 0.29
(0.27%)

GBP-INR

123.51 0.42
(0.34%)

JPY-INR

0.58 0.00
(0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5573934

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

23.84

110631.93

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.6

Back

Hindalco Industries consolidated net profit declines 45.14% in the December 2025 quarter

Feb 12,2026

Net profit of Hindalco Industries declined 45.14% to Rs 2049.00 crore in the quarter ended December 2025 as against Rs 3735.00 crore during the previous quarter ended December 2024. Sales rose 13.93% to Rs 66521.00 crore in the quarter ended December 2025 as against Rs 58390.00 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	66521.00	58390.00	14
OPM %	12.01	12.99	-
PBDT	7659.00	7276.00	5
PBT	5439.00	5337.00	2
NP	2049.00	3735.00	-45

76,361.53 -502.18 ( -0.65%)

47,431.94 -295.58 (-0.62%)

6,795.43 -7.05 (-0.10%)

55,018.23 769.84 (1.42%)

10,315.38 -96.86 (-0.93%)

91.90 -0.24 (-0.26%)

106.87 0.29 (0.27%)

123.51 0.42 (0.34%)

0.58 0.00 (0.09%)